Palomino Laboratories Inc.
Business Overview: Palomino Laboratories Inc. (OTCQB: PALX)
Executive Summary
Palomino Laboratories Inc. is a pre-revenue, fabless semiconductor company developing gallium nitride (GaN) microLED-based optical transceivers — chips designed to move data between computers using light instead of copper wiring — aimed at AI servers, cloud computing, and high-performance computing (HPC) data centers. The company is headquartered in Goleta, California, next to the University of California, Santa Barbara (UCSB), from which it licenses its core microLED technology.
Palomino became a public company through a reverse merger with a shell company (Unite Acquisition 3 Corp.), completed September 29, 2025, and its common stock began trading on the OTCQB Venture Market under "PALX" on April 17, 2026 at a $4.00 private-placement offering price. The company has generated no revenue from commercial sales to date and is funding operations with cash raised through private placements and SAFE-note conversions rather than product sales. Its investment case rests entirely on whether its GaN microLED approach to optical I/O can be validated and adopted by data-center customers before cash runs out or incumbent optical-component suppliers close the gap.
1. Core Business Model & How They Work
Palomino operates a fabless model: it designs and markets optical transceiver chips while outsourcing physical chip manufacturing to third-party fabrication partners, rather than owning its own semiconductor fab.
[ UCSB microLED IP License ] ➞ [ Chip & Module Design (Palomino) ] ➞ [ Outsourced Fabrication ] ➞ [ Optical Transceiver Product ] ➞ [ AI Data Center / HPC Customers ]The company's core technical bet is that microLED-based optical links can move data between servers and chips with better power efficiency and lower cost than the VCSEL (vertical-cavity surface-emitting laser) and edge-emitting laser technology that dominates today's optical transceiver market. As of its most recent annual report, the company had not yet built a production facility or commenced production, and it has not disclosed commercial customers, purchase orders, or revenue — it remains in the technology-development and fundraising stage rather than full commercial operation.
2. Technology & Product Portfolio
Palomino is a single-product, pre-commercial company; there is no multi-segment breakdown to report. Its offering is best described as a technology platform rather than a shipping product line:
| Offering | Category | Purpose | Why It Matters |
|---|---|---|---|
| GaN microLED Optical Transceiver Platform | Optical I/O component (in development) | Moves data optically between servers/chips in AI and HPC data centers, replacing copper interconnects and competing with VCSEL-based transceivers. | Core and only product; not yet in commercial production or generating sales. |
| UCSB-Licensed microLED IP | Licensed core technology | Underpins the company's optical engineering approach. | The company's primary technical asset; its commercial value is unproven outside lab/demonstration settings. |
3. Competitive Landscape
The 10-K describes today's optical transceiver market as dominated by VCSEL and edge-emitting laser suppliers, against which Palomino is a very small, pre-revenue challenger:
- Incumbent optical-component suppliers: Lumentum, Coherent, Broadcom, and OSRAM Opto Semiconductors are named as the established players whose VCSEL/edge-emitting-laser and (in Broadcom's case) co-packaged-optics technology currently serves the AI/data-center optical interconnect market at commercial scale.
- Emerging microLED competitor: Avicena Tech, developer of the "LightBundle" microLED interconnect approach, is named as a direct rival pursuing a similar microLED-based optical I/O strategy.
- Broader market context: Co-packaged optics (CPO) and next-generation optical interconnects are a well-funded, closely watched segment of the AI infrastructure buildout, which is attracting significant competitive and capital attention from large, better-resourced incumbents — a dynamic that cuts against any small, early-stage entrant's ability to control the pace of adoption.
Palomino argues its GaN microLED approach offers a more scalable, lower-cost path than VCSEL technology, but as a pre-revenue company it has not yet demonstrated this claim commercially against any of the above competitors.
4. Strategic Strengths & Risks
Potential Strengths
- University-origin IP: The company's core microLED technology is licensed from UCSB, giving it a specific, named technical starting point rather than a purely conceptual pitch.
- Thematic tailwind: Optical interconnects for AI data centers are a genuine, fast-growing area of infrastructure spending, so Palomino is targeting real demand rather than a hypothetical market.
- Balance sheet runway: Following an April 2026 private placement that raised $16.975 million gross ($4.00/share, led by placement agent Laidlaw & Company), the company reported $19.4 million in cash and $20.6 million in stockholders' equity as of June 30, 2026 — enough, per management, to fund operations for at least a year without needing commercial revenue.
Key Risks
- No revenue, no proven product: Palomino has generated no revenue from commercial sales and has not disclosed a production facility in operation; it remains a development-stage story.
- Competitive and execution risk: It is competing against far larger, better-capitalized incumbents (Lumentum, Coherent, Broadcom, OSRAM) as well as another dedicated microLED challenger (Avicena), with no manufacturing scale or customer base of its own yet.
- Dilution risk: The company has funded itself through successive private placements and SAFE conversions and explicitly warns that future equity raises could cause substantial dilution to existing shareholders.
- Thin, newly-formed public float: PALX has only traded on the OTCQB since April 2026 following a reverse merger with a blank-check shell, with low historical trading volume — a structure and trading history that typically carries elevated volatility and limited analyst coverage.
- Emerging-growth-company reporting: Reduced disclosure requirements under its emerging-growth-company status may limit investor visibility relative to a seasoned filer.
5. Financial Overview
| Metric | Palomino Laboratories (PALX) | Strategic Context |
|---|---|---|
| Revenue | $0 (pre-revenue) | No commercial sales to date; all spending is development/overhead. |
| Cash & Equivalents (6/30/2026) | ~$19.4 million | Funded almost entirely by private placements and SAFE conversions, not operations. |
| Total Assets / Stockholders' Equity (6/30/2026) | ~$21.0M / ~$20.6M | Balance sheet is essentially a cash shell plus early-stage IP and equipment; equity roughly tracks cash on hand. |
| Net Loss | ~$2.6 million (H1 2026); $3.16 million (FY2025) | Losses driven mainly by R&D and G&A as the company builds out its technology and public-company infrastructure. |
| R&D / G&A Expense (H1 2026) | ~$1.1M / ~$1.5M | Spending is split roughly evenly between core technology development and corporate overhead — typical of an early-stage, newly-public developer. |
| Capital Raised | ~$8.0M (Oct. 2025) + ~$1.7M (follow-on) + $1.845M SAFE conversion + ~$17.0M gross (April 2026) | Company has relied on four separate financing events within about a year to reach its current cash position. |
6. Summary Conclusion
Palomino Laboratories is a speculative, pre-revenue optical-semiconductor developer whose entire story currently rests on a UCSB-licensed GaN microLED technology bet in the fast-growing AI data-center optical interconnect market. It has real, specific technology and a well-funded balance sheet (roughly $19-20 million in cash and equity as of mid-2026) to pursue it, but no revenue, no disclosed production facility, and no commercial customers — and it is pursuing this strategy against far larger incumbent optical-component suppliers (Lumentum, Coherent, Broadcom, OSRAM) as well as a dedicated microLED rival (Avicena Tech). Having only become public via a reverse merger with a blank-check shell in September 2025 and begun OTCQB trading in April 2026, PALX is best understood today as an early-stage technology bet rather than a company with an established competitive moat.